Search results for "Statins"
Societies stress shared decision making in updated lipids performance measures
Better patient outcomes are realized only if patients agree with, act on, and adhere to their doctors' advice for 5 to 10 years, but up to half of patients stop statins at 1 to 2 years.
https://immattersacp.org/weekly/archives/2015/12/15/5.htm
15 Dec 2015
MKSAP Quiz: 10-month history of generalized weakness
A 61-year-old man is evaluated for a 10-month history of generalized weakness. He reports no pain or myalgia. History is significant for hypercholesterolemia treated with a stable dose of simvastatin for the past 3 years. Following a physical exam, lab results, and a chest radiograph, what is the most likely diagnosis?
https://immattersacp.org/weekly/archives/2015/12/22/3.htm
22 Dec 2015
ARBs may offer same efficacy, better tolerability than ACE inhibitors
Meta-regression analysis showed that the difference between angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) compared with placebo was due to a higher placebo event rate in the ACE inhibitor trials for the outcome of all-cause mortality, cardiovascular death, and myocardial infarction.
https://immattersacp.org/weekly/archives/2016/01/12/6.htm
12 Jan 2016
Statins associated with fewer major adverse coronary events, mortality in those with low ankle-brachial index
Clinicians should optimize therapy for people with clear indications for statin therapy, including those with diabetes, an editorial suggested.
https://immattersacp.org/weekly/archives/2016/02/09/5.htm
9 Feb 2016
Managing Alzheimer's disease when options are limited
Primary care physicians can expect to diagnose an increasing number of patients with Alzheimer's disease as the U.S. population ages. While clinicians have been more successful in diagnosing the disease early, effective treatments or prevention options are more scarce.
https://immattersacp.org/archives/2016/03/alzheimers.htm
1 Mar 2016
There are challenges when translating research to practice
Despite convincing results for many health care interventions, translating evidence from research into clinical practice is often challenging. What works in a research environment may not function in practice.
https://immattersacp.org/archives/2016/04/policy.htm
1 Apr 2016
Statin treatment reduced cardiovascular events more than hypertension drugs in intermediate-risk patients, study finds
An accompanying editorial said that the results of this trial support the benefits of statins for primary prevention and a risk-based approach to prescribing, rather than one based on LDL levels.
https://immattersacp.org/weekly/archives/2016/04/05/1.htm
5 Apr 2016
PCSK9 inhibitor appears more effective than ezetimibe for short-term LDL lowering in small, randomized trial
The authors of an accompanying editorial noted that PCSK9 inhibitors like evolocumab are not approved for the indication in the trial and have not yet been shown to reduce cardiovascular events.
https://immattersacp.org/weekly/archives/2016/04/05/5.htm
5 Apr 2016
Guidance issued on nonstatin therapies for cholesterol lowering
The goal of the decision pathway was to provide practical guidance for clinicians and patients in situations not covered by the 2013 ACC/AHA guideline until new clinical guidelines on the topic are published.
https://immattersacp.org/weekly/archives/2016/04/05/4.htm
5 Apr 2016
Sustained change a challenge for health
Health-linked incentives have become increasingly common, particularly by employers. But researchers are still trying to sort out what type and design of incentives are most effective and whether they hold significant potential to achieve both short- and long-term behavioral changes.
https://immattersacp.org/archives/2016/05/lifestyle.htm
1 May 2016